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osting by EAbstract Introduction: Pulmonary vein (PV) isolation is considered the cornerstone of atrial
ﬁbrillation (AF) catheter ablation. PV isolation (PVI) by means of cryotherapy has emerged as a
promising technique due to both a low thrombogenicity and reduced risk of PV stenosis. The eval-
uation (need/efﬁciency/safety) of hybrid therapy (deﬁned as the use of cryotherapy followed by that
of radiofrequency energy in a given patient) is the aim of the present study.
Methods: Thirty-four consecutive patients (26 men, mean age: 56.7 ± 9.3 years) with symptomatic
drug-refractory paroxysmal AF underwent PVI using a balloon-cryotherapy (BCT). A maximum of
four cryotherapy applications was applied per PV and disconnection assessed thereafter using a cir-
cular LASSO catheter. When necessary, PV disconnection was then performed using a 4 mm
irrigated-tip catheter. All patients underwent CT-scan evaluation before discharge to detect acute
PV stenosis.
Results: PVI could be achieved in all patients. Mean procedure duration was 230 ± 42 min and
mean ﬂuoroscopy time was 52 ± 13 min. Hybrid therapy was needed to achieve PVI in 26 of 34
(76%). With cryoablation solely, PVI was achieved in 90 of 136 (66%) targeted veins, efﬁcacy beingge.fr (A. Abdelaal).
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98 A. Abdelaal et al.higher in superior as compared to inferior PVs (87% vs. 46%, p< 0.001). Besides one patient with
permanent right phrenic nerve injury, no other procedure-related complications were observed.
After a mean follow-up period of 8 ± 3 months, 28 patients (82%) did not experience AF recur-
rence (including six patients on antiarrhythmic drugs).
Conclusions: Our study suggests that hybrid ablation therapy is necessary in most patients to
achieve PV disconnection after a maximum of four blinded applications of balloon-cryotherapy
(especially in inferior PVs), with a signiﬁcant short-term success rate.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Focal ablation of triggers within the PV was described as a
curative tool for AF treatment1 to be modiﬁed later to segmen-
tal or antral PV ablation.2 Different ablation strategies and
techniques have been developed to achieve efﬁcient PV electric
isolation (PVI). Cryotherapy evolved as an effective and safe
catheter ablation tool for treating various arrhythmic sub-
strates.3,4 The introduction of BCT has allowed antral PV elec-
tric isolation, however anatomical and technical challenges
may contribute to relatively long procedure and ﬂuoroscopic
exposure times using it as a sole ablation tool.5 The evaluation
(need/efﬁciency/safety) of hybrid therapy (deﬁned as the use of
BCT followed by that of radiofrequency energy in a given
patient) is the aim of the present study.
2. Methods
2.1. Patients’ characteristics
The study population consists of 34 consecutive patients (26
men, mean age: 56.7 ± 9.3 years) with symptomatic drug-
refractory paroxysmal AF of 5.3 ± 3.5 years duration. A mean
of 3 ± 0.7 antiarrhythmic drugs had failed to control AF prior
to the ablation procedure. Two patients had hypertensive
cardiomyopathy, two had coronary artery disease, one had
hypertrophic cardiomyopathy, one had mild rheumatic mitral
stenosis, one had aortic valve prosthesis and 23 had no evidence
of structural heart disease.
2.2. Patients’ preparation
Left atrial anatomy was assessed 1 day preceding the electro-
physiological study as all patients underwent an ECG-gated
helical multislice CT scan of the chest. Images were acquired
using a 64 row multidetector CT scanner (GE Light-Speed,
GE Healthcare), where the LA volume, the number, size and
shape of the PV could be assessed. PV shape was assessed by
calculating the PV index as described previously.6 All patients
provided a written informed consent. Oral anticoagulants were
replaced on admission by intravenous heparin to maintain a
partial-thromboplastin time of 60–90 s (control, 30 s), and a
transesophageal echocardiogram was performed before each
procedure to exclude LA thrombus.
2.3. Electrophysilogic procedure and ablation
Through a right femoral venous approach, a 5F quadripolar
catheter (XTREM, ELA Medical, Sorin Group) was
advanced in the distal coronary sinus. Left atrium was accessed
through a transseptal puncture using an 8F long sheath (SL1,St. Jude Medical), to be replaced over a guide wire by a 12F
transseptal sheath (FlexCath, Cryocath). Subsequently, intra-
venous heparin was administered at a dose of 0.5 mg/kg, fol-
lowed by a repeat bolus to ensure an antithrombin
coagulation time constantly >250 s. Sedation was obtained
with 10 mg nalbuphine intravenous with incremental doses of
5 mg as necessary throughout the procedure.
A circular mapping catheter (LASSO, Biosense-Webster)
introduced through the transseptal sheath was placed on the
PVs ostia (deﬁned by PVs angiography) to record PV poten-
tials prior to PV ablation (Fig. 1). Bipolar electrograms (band
pass, 30–500 Hz) were recorded on a multichannel polygraph
(LabSystem PRO, Bard Electrophysiology).
The circular mapping catheter was replaced by a 12F bal-
loon catheter. One of two available balloon sizes (23 or
28 mm) was chosen with respect to the PV ostial dimensions
on the CT scan images. The balloon catheter was inﬂated in
the left atrium and advanced to occlude the ostium of each
PV. Depending on the quality of PV occlusions assessed by
PV angiograms (Fig. 1), a minimum of two average or good
occlusions should be achieved per PV and within a maximum
of four applications (5 min per application). Occlusion of the
PV were classiﬁed as good (no contrast leakage), average (leak-
age of contrast from one of the four quadrants of each PV;
anterior, posterior, inferior and superior quadrants), and bad
(leakage of contrast from more than one quadrant of the PV
ostia). The quadripolar catheter was placed in the superior
vena cava for phrenic nerve pacing during BCT application
for the right PVs. If any loss of capture was detected, BCT
was terminated immediately (Fig. 2).
The balloon catheter was replaced by the circular Lasso
catheter to check for PV electric isolation (Fig. 1).
If electric isolation of any of the targeted PV was not
achieved by the BCT solely, hybrid radiofrequency ablation
was applied as a 4 mm irrigated-tip catheter was introduced
to the left atrium targeting the PV electric potentials on the
Lasso catheter. Radiofrequency energy was delivered to
PV-atrial electric connections with a power of 25–30 W using
irrigation rates of 5–60 ml/min (0.9% saline via a Cool Flow
pump; Biosense-Webster) to achieve the desired power deliv-
ery. RF energy applications were discontinued when the local
PV electrograms were abolished on the circular mapping
catheter.
2.4. Post ablation management
A control transthoracic echocardiogram was performed within
2 h after ablation and the day after. A control chest CT-scanwas
performed on the day after ablation to detect early PV stenosis.
Oral anticoagulants were reinitiated the day after ablation and
maintained for at least 6 weeks. Heparin administration was
Figure 1 Intracardiac tracings of the PV potentials detected on the Lasso catheter placed at the 4 PV ostia before cryo application (A) and
following cryo application (B). Note the residual PV potentials in both LIPV&RIPV denoting incomplete PV isolation. LSPV: left superior
pulmonary vein, LIPV: left inferior pulmonary vein, RSPV: right superior pulmonary vein & RIPV: right inferior pulmonary vein.
Figure 2 An example showing the balloon accluding the 4 PV with veriﬁcation of occlusion using contrast injection. Note the proper
occlusion of all the PV (A–C) except the RIPV that shows contrast lealage at its inferior border shown by the white arrow (D). A
quadripolar catheter is placed in the SVC for phrenic nerve pacing during cryo ablation of the RSPV (C). LSPV: left superior pulmonary
vein, LIPV: left inferior pulmonary vein, RSPV: right superior pulmonary vein & RIPV: right inferior pulmonary vein.
Pulmonary vein isolation 99maintained (intravenously for 24 h then subcutaneously) for
3 days after the international normalized was >2.
Patients were monitored by telemetry for at least 3 days after
ablation, thendischargedand followedonanout-patientbasiswith
clinical evaluationand24-hHolter recordingsperformedregularly.
All antiarrhythmic drugs were discontinued following the proce-
dure unless AF recurrence was detected during follow up.
3. Results
A total of 34 patients were enrolled in the study. Totalmean pro-
cedure duration was 230 ± 42 min and a mean ﬂuoroscopic
exposure time was 52 ± 13 min. When using the 23 mm
cryoballoon, the total procedure timewas insigniﬁcantly shorter
(219 ± 36 min) compared to the 28 mm cryoballon (241 ±
44 min). Total ﬂuoroscopic exposure timewas the same for both
balloons (44 ± 13 vs. 44 ± 14 min for the 23 and 28 mm bal-
loons, respectively).As measured on the CT scan images, mean LA volume was
111 ± 23 ml, a total of 136 PV were identiﬁed to be targeted for
ablation and isolation. BCT alone was not sufﬁcient to achieve
isolation of all the PV in 26 patients (76% of patients) where hy-
brid radiofrequency therapywas needed toachieve completePVI.
3.1. PVI using BCT alone
Isolation of PV was achieved in 90 of 136 (66%) targeted veins
using BCT alone with the highest efﬁcacy in the superior PVs
compared to the inferior PVs (87% vs. 46%, p< 0.001).
Electric isolation using BCT alone was observed in 88% of
LSPV (30/34), 85% of RSPV (29/34), 64% of LIPV (22/34)
and 26% of RIPV (9/34).
Pulmonary vein index was the predictor of successful PVI
using BCT alone for the left PVs. whereas for the right PVs,
no clinical or anatomical factors were identiﬁed as predictors
of successful PVI (Table 1).
Table 2 Minimum temperature achieved during cryotherapy in isolated and non-isolated PV.
LSPV LIPV RSPV RIPV
Minimum temperature in isolated PV 55 ± 10 C 54 ± 10 C 58 ± 9 C 51 ± 8 C
Minimum temperature in non-isolated PV 40 ± 6 C 41 ± 5 C 48 ± 5 C 39 ± 5 C
P-value <0.05 <0.05 <0.05 <0.05
Table 1 Pulmonary vein index for isolated and non-isolated PV.
LSPV LIPV RSPV RIPV
Isolated PV index 1.2 (1.1–1.5) 1.2 (1–1.7) 1.1 (1–1.7) 1.1(1–1.2)
Non-isolated PV index 1.7 (1.6–1.7) 1.5 (1–1.5) 1.1 (1.1–1.7) 1.2 (1–1.4)
P-value <0.05 <0.05 NS NS
Table 4 AF recurrence during follow up.
AF recurrence
with antiarrhythmics
AF recurrence
without
antiarrhythmics
All patients (n= 34) 12/34 (35%) 6/34 (16%)
BCT alone (n= 16) 5/16 (31%) 1/16 (6%)
Hybrid therapy (n= 28) 7/28 (25%) 5/28 (18%)
P value NS <0.05
Table 3 Duration of hybrid RF energy applied to achieve
complete PVI.
LSPV LIPV RSPV RIPV
Mean RF duration (min) 1.9 ± 0.9 2.8 ± 1 1.2 ± 0.5 3.3 ± 1.2
100 A. Abdelaal et al.The mean temperature achieved during cryotherapy was
signiﬁcantly lower in all isolated PV compared to non-isolated
ones (Table 2).
3.2. PVI using hybrid therapy in comparison to BCT alone
Following BCT, radiofrequency energy was needed to achieve
complete isolation in 46 PV. The mean RF duration applied
was 2.8 ± 1.3 min with the highest duration at the RIPV
and the lowest at the RSPV (Table 3).
4. Complications
Besides one patient with permanent right phrenic nerve injury,
no other procedure-related complications were observed.
4.1. Recurrence rate
After a mean follow-up period of 8 ± 3 months, 28 patients
(82%) did not experience AF recurrence (including six patients
on antiarrhythmic drugs. AF recurrence rate was signiﬁcantly
higher in patients using hybrid therapy (18%) compared to
BCT alone (6%) (Table 4).
5. Discussion
Successful PVI remains a cornerstone in the ablative therapy
of atrial ﬁbrillation.1 Cryo energy ablation of the PV using a
balloon has been described as a therapeutic approach for cir-
cumferential PV ablation.5 Long procedure time, ﬂuoroscopic
exposure and the ability to isolate all PV remained as technical
challenges for BCT procedures.7
In our study, we evaluated the utilisation of BCT for AF
ablation. In addition we studied the feasibility and efﬁcacy
of hybrid RF ablation as a complement to BCT.
In this study, 66% of the PV were successfully isolated with
BCT alone which is slightly lower than the 84% and the 98%
achieved by Van Belle et al.7 and Chun et al.5 This could be
explained by the fact that our cryo applications were limited
to a maximum of four before shifting to hybrid RF therapy.
In agreement with other studies,5 the RIPV was the most
challenging to achieve isolation using BCT. It was the only
PV that could not be isolated in the single big cryoballoon
study by the Hamburg group.5 This could be attributed to
anatomical challenges to rotate the whole transseptal sheathand the balloon to occlude the RIPV due to the small endolu-
minal distance between the fossa ovalis and the RIPV.8
It has been proven in our study that the anatomical shape
of the PV ostia is a major determinant to achieve acute PVI
using BCT for most of the PV. The PV index which is an indi-
cator of the PV ostium shape was directly related to successful
PV isolation with BCT.
Achieving lower balloon temperature was associated with
successful PVI using BCT which could be attributed to better
occlusion and contact at the PV. This has been proved recently
by the Hamburg group.7
It has been proved in animal models that delivering RF and
cryoenergy, simultaneously and sequentially was as effective as
delivering any of them independently.9 However in our study,
patients with hybrid therapy had a higher recurrence rate com-
pared to BCT alone during the follow up period. This ﬁnding
may raise the question on the effect of RF energy following
cryoenergy on the long term lesion evolution.
6. Conclusion
Our study suggests that hybrid ablation therapy is necessary in
most patients to achieve PV disconnection after a maximum of
four blinded applications of balloon-cryotherapy. Radiofre-
quency energy following cryoenergy may be responsible for
higher recurrence rates post ablation.
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